- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Amersham chair plans departure
Fourteen-year company veteran Richard Lapthorne will step down as Amersham chairman of the board May 7. Donald Brydon, who has been a nonexecutive director of Amersham for six years and is chair of the company's audit committee, will succeed him.
Fourteen-year company veteran Richard Lapthorne will step down as Amersham chairman of the board May 7. Donald Brydon, who has been a nonexecutive director of Amersham for six years and is chair of the company's audit committee, will succeed him. Lapthorne joined the Amersham board as a nonexecutive director in 1988. He served four years as chairman.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
